PEREGRINE PHARMACEUTICALS INC·4

Nov 1, 5:30 PM ET

PEREGRINE PHARMACEUTICALS INC 4

4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2013

Insider Transaction Report

Form 4
Period: 2013-10-31
KING STEVEN W
DirectorPresident & CEO
Transactions
  • Other

    Common Stock

    2013-10-31$1.08/sh+4,131$4,461191,534 total
Footnotes (1)
  • [F1]Shares acquired under the issuer's employee stock purchase plan on October 31, 2013.

Documents

1 file
  • 4
    sking_frm4-103113.xmlPrimary

    FORM 4